School of Medicine
Showing 801-900 of 5,029 Results
-
Stephanie Chow
Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology
BioDr. Chow is a fellowship-trained gynecologic oncologist. She is a clinical assistant professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.
She treats the full spectrum of gynecologic cancers, including cervical, endometrial, ovarian, vaginal, and vulvar. She emphasizes minimally invasive treatment and performs laparoscopic and robotic surgery.
Dr. Chow works closely with radiation oncology, genetics, and other oncologic specialists in a multidisciplinary setting to provide high quality, evidence-based, and individualized care. Dr. Chow is a strong advocate for patient education and strives to deliver compassionate care to patients and their families.
Dr. Chow has conducted extensive clinical research. Her work has focused on the role of the sentinel lymph node biopsy technique for gynecologic cancer, therapeutic vaccines for ovarian cancer, the impact of race on the development of uterine cancer, and other topics. She has published in Molecular Cancer Therapeutics, Gynecologic Oncology, Scientific Reports, and other peer-reviewed journals.
Dr. Chow has also won numerous honors and awards for her scholarship and research achievements. In fellowship, she earned the AACR Doreen J. Putrah Cancer Research Foundation Scholar-In-Training Award. She was also awarded the AAGL Recognition of Excellence in Minimally Invasive Gynecology.
Dr. Chow is a member of the Society of Gynecologic Oncology (SGO), American Association for Cancer Research (AACR), American Association of Gynecologic Laparoscopists (AAGL), and American College of Obstetricians and Gynecologists (ACOG). -
Kamilee Christenson, MD
Adjunct Clinical Assistant Professor, Obstetrics & Gynecology - General
Current Research and Scholarly InterestsImproving access to effective birth control. Improving access to safe abortions.
-
Antonios Chronopoulos
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research focuses on understanding how extracellular matrix (ECM) remodeling in liver fibrosis, particularly in the context of aging, diabetes, and metabolic-associated steatohepatitis (MASH), disrupts tissue mechanical homeostasis and drives hepatocellular carcinoma pathogenesis. The goal is to translate these mechanobiological insights into novel therapies targeting mechanotransduction to prevent or reverse fibrosis and improve patient outcomes with liver cancer and other desmoplastic tumors
-
Alvina Dor-Yan Chu
Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.
She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students. -
Andrew Chu, MD, MPH, MBA
Clinical Assistant Professor, Emergency Medicine
BioDr. Chu is a board-certified emergency medicine physician and clinical assistant professor in the Department of Emergency Medicine. He is passionate about integrating lean startup methodologies into daily academic practice and has a decade of experience leading multi-disciplinary teams in designing, developing, and launching award-winning healthcare technologies. Dr. Chu is currently working with his colleagues to build AI solutions that will improve clinical operations for the emergency department.
He is also part of the Stanford EM Partners Program (STEPP), where he evaluates and executes on promising academic-industry partnerships. He is also an active committee member and former co-chair for the Stanford EM Innovation Conference, the premier virtual conference on AI and innovation for the acute care space.
He completed his residency in emergency medicine at the Harvard affiliated Mass General Brigham program. He received his applied research fellowship in healthcare innovation at Harvard Medical School. He also completed the Stanford Biodesign Faculty Fellowship. He pursued a medical degree at Boston University, a Master of Public Health (MPH) degree at Harvard, and a Master of Business Administration (MBA) degree at the Quantic School of Business and Technology.
He is a member of the American College of Emergency Physicians, American Academy of Emergency Medicine, and Society of Academic Emergency Medicine. -
Constance Chu, MD
Professor of Orthopaedic Surgery (Sports Medicine)
BioDr. Constance R. Chu is Professor and Vice Chair Research, in the Department of Orthopedic Surgery at Stanford University. She is also Director of the Joint Preservation Center and Chief of Sports Medicine at the VA Palo Alto. Previously, she was the Albert Ferguson Endowed Chair and Professor of Orthopaedic Surgery at the University of Pittsburgh. She is a clinician-scientist who is both principal investigator of several projects funded by the National Institutes of Health and who has been recognized as a Castle-Connelly/US News and World Report “Top Doctor” in Orthopedic Surgery as well as on Becker’s list of Top Knee Surgeons in the United States. Her clinical practice focuses on the knee: primarily restoration and reconstruction of the ACL, menisci and cartilage. She graduated from the U.S. Military Academy at West Point and earned her medical degree from Harvard Medical School.
As Director of the multi-disciplinary Joint Preservation Center structured to seamlessly integrate the latest advances in biologics, mechanics, and imaging with comprehensive patient centered musculoskeletal and orthopedic care, Dr. Chu aims to develop a new model for health care delivery, research and education with an emphasis on health promotion and prevention. Cornerstones of this program include teamwork and a focus on personalized medicine. A central goal is to transform the clinical approach to osteoarthritis from palliation to prevention. In addition to optimizing clinical operations, outstanding research is critical to developing more effective new treatments. Towards this end, Dr. Chu is leading innovative translational research from bench to bedside in three main areas: quantitative imaging and biomarker development for early diagnosis and staging of joint and cartilage injury and degeneration; cartilage tissue engineering and stem cell based cartilage repair; and molecular and biological therapies for joint restoration and joint rejuvenation. Her research efforts have led to more than 30 professional awards and honors to include a Kappa Delta Award, considered to be the highest research honor in Orthopedic Surgery.
Dr. Chu also regularly holds leadership and committee positions in major professional organizations such as the American Association of Orthopedic Surgeons (AAOS) and the American Orthopedic Association (AOA). In her subspecialty of Orthopedic Sports Medicine, she is a past President of the Forum Sports Focus Group, a member of the Herodicus Society of leaders in Sports Medicine, and immediate past Chair of the American Orthopedic Society for Sports Medicine (AOSSM) Research Council. She is alumnus of the AOA American, British, Canadian (ABC) and the AOSSM Traveling Fellowships. -
Derek Chu, MD
Clinical Associate Professor, Dermatology
Clinical Associate Professor (By courtesy), PediatricsBioDerek Chu, M.D., is Clinical Associate Professor of Dermatology and Pediatrics at Lucile Packard Children's Hospital. He completed his medical school and residency training at the University of Pennsylvania, followed by a pediatric dermatology fellowship at UCSF. Dr. Chu's clinical interests encompass a wide array of topics within pediatric dermatology, including vascular tumors and malformations, inflammatory skin diseases, dermato-oncology, neonatal dermatology, and procedural dermatology.
Email: derekchu@stanford.edu -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.
For a full description of my educational informatics work, please see my website aim.stanford.edu.
My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.
I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.
The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain. -
Steven Chu
William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering
Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioAlex Weihan Chu, M.D. serves as a Clinical Assistant Professor at Stanford School of Medicine and is the Associate Chief Medical Officer and Vice President of Quality, Health Equity, and Clinical Affairs at Stanford Health Care Tri-Valley.
Dr. Chu has been a dedicated member of SHC Tri-Valley since 2015, joining as a Hospital Medicine physician after completing his residency at Stanford Hospital. He is board-certified in Internal Medicine and Clinical Informatics. Since 2016, he has served as the Medical Informatics Director, a role he continues to oversee, ensuring that technology enhances clinical workflows and patient care.
Dr. Chu has held multiple leadership roles, including serving on the Medical Executive Committee and as Vice Chief of Medicine. He previously served as Associate Chief Medical Officer for Patient Safety, Infection Control & Accreditation, Regulatory & Licensing, where he played a key role in supporting Joint Commission surveys, ensuring CDPH compliance, and leading hospital safety initiatives to address regulatory findings.
In 2024, Dr. Chu transitioned to his current role, the Associate Chief Medical Officer and Vice President for Quality, Health Equity, and Clinical Affairs where he is responsible for coordinating a comprehensive system of quality monitoring and improvement to achieve excellent patient care. He works closely with Kathleen Carrothers, Senior Director of Quality Management and Performance Improvement, to oversee clinical outcomes, data management, and performance improvement initiatives. He also leads health equity efforts and manages physician agreements, ensuring sustained high-quality care and strategic physician engagement.
Dr. Chu brings expertise in physician engagement, clinical oversight, clinical informatics, and quality improvement. His experience in driving multi-disciplinary change and advancing health equity to aligns with the hospital’s mission and vision.
Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring the latest advancements in technology. -
Ian Chua
Clinical Associate Professor, Pediatrics
BioIan Chua, MD, MHPE, MBA is a bicoastal pediatric hospitalist and clinical associate professor of pediatrics at Stanford Children’s Health (Palo Alto, CA) and Children’s National Medical Center (Washington, DC). He completed his residency at Stanford Children’s with concentrations in medical education and quality improvement. He obtained his Masters’ in Health Professions Education at University of Illinois in Chicago. He currently co-directs the Quality and Leadership Training (QUILT) program in the department of pediatrics as well as the PHM Leadership Rotation. He also directs the ACGME Fellows’ Common Core Curriculum, the PHM Fellowship Medical Education Pathway, and the Pediatric residency medical education pathway at Children’s National Medical Center. His interests have been in educational scholarship and professional development of transitional learners including junior faculty. Nationally, he has been involved in shaping the national PHM fellows' conference and is the current co-chair for the AAP SOHM Emerging Leaders Conference.
-
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
On Partial Leave from 02/01/2026 To 08/31/2026Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
-
Cynthia Chuang
Clinical Professor, Radiation Oncology - Radiation Physics
BioEducation:
1990-B.S., Bioelectrical Engineering (6-1B), Massachusetts Institute of Technology, Cambridge, MA
1992-M.S., Bioengineering, University of Pennsylvania, Philadelphia, PA
1994-M.S., Nuclear Engineering (NMR Spectroscopy), Massachusetts Institute of Technology, Cambridge, MA
1999-Ph.D., Nuclear Engineering (Boron Neutron Capture Therapy), Massachusetts Institute of Technology, Cambridge, MA
2001-Postdoctoral Fellowship (Peregrine Project), Lawrence Livermore National Laboratory
2003-Medical Physics Residency, University of California, San Francisco (joint 3.5-year postdoctoral and residency program)
Academic Appointments:
2003 - 2005-Clinical Instructor, Radiation Oncology, University of California, San Francisco, San Francisco, California
2005 - 2009-Assistant Adjunct Professor, Radiation Oncology, University of California, San Francisco, San Francisco, California
2009 - 2013-Assistant Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California
2013 - 2017-Associate Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California
2017 - 2018-Associate Professor of Clinical Radiation Oncology, University of California, San Francisco, San Francisco, California
2019 - 2023-Clinical Associate Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA
2023- Present-Clinical Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA -
Henry Chubb
Clinical Associate Professor, Pediatrics - Cardiology
Current Research and Scholarly Interestshttps://www.researchgate.net/profile/Henry_Chubb
-
Benjamin I. Chung
Professor of Urology and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsRenal cell carcinoma and prostate cancer outcomes research and epidemiology.
-
Lorinda Chung
Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.
-
Philip Chung
Instructor, Anesthesiology, Perioperative and Pain Medicine
BioI am a general anesthesiologist and healthcare AI researcher. My areas of research focus on large language model applications in perioperative medicine and anesthesiology, particularly for clinical reasoning, risk prediction, and documentation generation to improve clinician workflows.
In addition to practicing at the Stanford hospital, I am also a member of Nima Aghaeepour's laboratory. See my CV and Google Scholar on the bottom right of this page for more information. -
Kirk Churukian
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioKirk A. Churukian MD, FACS is board certified by the American Board of Plastic Surgery. Dr. Churukian completed training in general surgery, plastic surgery, and hand surgery. He was board certified in general surgery and is currently board certified in plastic surgery.
Dr. Churukian is a member of several local, state, and national professional societies and has practiced in the Los Gatos/San Jose areas for more than 20 years. He tries to bring a friendly, creative, and patient focused approach to his cosmetic and reconstructive surgery practice.
In addition to his private cosmetic practice, Dr. Churukian serves the community as a trauma specialist at San Jose Regional Medical Center. At this level II Trauma Center, he specializes in facial and orbital fracture repair and complex reconstructive surgery of the trunk and extremities. He also maintains an ongoing commitment to enhancing self-image with breast reconstruction for cancer survivors.
Dr. Churukian grew up as a first generation eldest son of Armenian parents in Southern California and attended the University of Southern California, graduating with a degree in Psychobiology. Always interested in athletics, He participated in swimming and water polo throughout high school and played club water polo in college. This interest in aquatics was transferred to his children, all of whom are swimmers, and two of whom are avid water polo players. He currently resides in Menlo Park, California and is currently still married to his first wife ;-). He enjoys supporting Stanford athletics, except when the USC Trojans come to town! -
Karlene Cimprich
Professor of Chemical and Systems Biology and, by courtesy, of Biochemistry
On Partial Leave from 03/01/2026 To 04/30/2026Current Research and Scholarly InterestsGenomic instability contributes to many diseases, but it also underlies many natural processes. The Cimprich lab is focused on understanding how mammalian cells maintain genomic stability in the context of DNA replication stress and DNA damage. We are interested in the molecular mechanisms underlying the cellular response to replication stress and DNA damage as well as the links between DNA damage and replication stress to human disease.
-
Andrea Cipriano
Instructor, Obstetrics & Gynecology - Reproductive Biology
Instructor, OB-GYN/Reproductive, Perinatal and Stem Cell Biology ResearchBioDr Andrea Cipriano is an instructor at the Stem Cell Institute and at the Ob/Gyn department at Stanford School of medicine. Since the beginning of his career he was driven by a deep interest in the complexities of life emerging from just a single cell, harboring all the instructions to produce a fully functional organism. His academic journey began with a Bachelor's in Biotechnology and progressed to a Master's in Genomic Biotechnology, where he delved into the intricate world of RNA. During his PhD, Andrea focused on long non-coding RNAs and their pivotal role in cell differentiation, a topic that continues to fascinate him in his current research. He works in the Sebastiano lab, and he is directing several projects, including studying the transcription factor TBX1 during development of the Pharyngeal endoderm, and exploring the impact of time on Chromatin Structure, particularly in the context of aging and its potential reversal. As an instructor, Andrea has been teaching for 4 years at the intensive CIRM stem cell class biology course. Teaching is a big passion that fuels his academic pursuits. His dedication to education stems from a deep-seated belief in the transformative power of knowledge, which is what initially propelled him into the academic world.
-
Robin Cisco, MD
Clinical Associate Professor, Surgery - General Surgery
BioDr. Robin Cisco is a board certified general surgeon and fellowship-trained endocrine surgeon. She specializes in surgery of the thyroid, parathyroid and adrenal glands and has expertise in lymph node dissection for thyroid cancer. Dr Cisco received her medical degree at Duke University before moving to Stanford for general surgery residency. During her residency, she completed a two-year research fellowship in surgical oncology, with a focus on cancer immunology.
After residency, she completed an endocrine surgery fellowship with the internationally recognized UCSF Division of Endocrine Surgery. She is the author of multiple publications related to endocrine surgery and surgical oncology and has an interest in minimally invasive approaches to thyroid, parathyroid and adrenal surgery. She is currently the Physician Leader of Stanford's Endocrine Oncology Cancer Care Program (CCP).
Dr. Cisco focuses on providing outstanding surgical care in an environment that is supportive of her patients and their families. She enjoys patient education and preoperative counseling, and seeks to lessen the anxiety that often comes with a recommendation for surgery. She currently sees patients both in San Jose at Stanford's Cancer Center South Bay and in Palo Alto in the Endocrine Oncology and Surgery clinic. -
Stephanie Cizek
Clinical Associate Professor, Obstetrics & Gynecology
Clinical Associate Professor (By courtesy), PediatricsBioI am a Pediatric and Adolescent Gynecologist, which combines my passion for gynecology with my love of working with children and young adults (and the people who care for them!). My approach to providing care is a collaborative one: my patients are individually unique and special, and their care should be tailored to be the best fit for them.
Prior to joining the Stanford faculty, I completed a fellowship in Pediatric and Adolescent Gynecology, From an academic standpoint, my current research focuses include: Gynecologic care for Oncology Survivors including Onco-Fertility and vulvovaginal graft-versus-host disease; gynecologic care of patients with Anorectal Malformations; Differences of Sex Development, Intersex conditions, and reproductive tract differences; and surgical care in pediatric gynecology. -
Thomas Clandinin
Shooter Family Professor
Current Research and Scholarly InterestsThe Clandinin lab focuses on understanding how neuronal circuits assemble and function to perform specific computations and guide behavior. Taking advantage of a rich armamentarium of genetic tools available in the fruit fly, combined with imaging, physiology and analytical techniques drawn from systems neuroscience, we examine a variety of visual circuits.
-
Daniel Clark, MD, MPH
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyBioDr. Clark is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. He is also a clinical assistant professor with dual appointments in the Division of Cardiovascular Medicine, Department of Medicine and the Division of Cardiology, Department of Pediatrics at Stanford University School of Medicine.
Dr. Clark specializes in the diagnosis and treatment of adult congenital heart disease (ACHD) and the management of congenital and acquired heart disease in children. His clinical focus involves the combined use of cardiac magnetic resonance (CMR) and other imaging techniques to evaluate patients with known or suspected cardiovascular disease. Dr. Clark’s extensive training and experience with these techniques include multiple fellowships in adult cardiology, cardiovascular imaging, and ACHD.
Dr. Clark is currently a co-investigator on multiple research studies. During his fellowship, he received a training grant from the National Institutes of Health enabling evaluation of the ability of CMR to diagnose COVID-19-associated heart inflammation among college athletes. He currently uses CMR to assess heart transplant outcomes in donors positive for hepatitis C virus. Dr. Clark also received a research grant from the Adult Congenital Heart Disease Association supporting a randomized, controlled clinical trial of cardiac rehabilitation among patients with Fontan failure.
Dr. Clark serves as a peer reviewer for multiple prestigious journals, including The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Journal of the American Heart Association (JAHA). He serves on the editorial board for both JAHA and Circulation: Cardiovascular Imaging. He is also a member of numerous professional medical societies, including the American College of Cardiology, the American Heart Association, and the Adult Congenital Heart Association. -
David Clark
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
BioMy career is dedicated to improving the safety, effectiveness and availability of pain relief. Both the needs and opportunities in these areas are limitless. I have had the good fortune of working as a clinician, teacher and scientist at Stanford University and the Palo Alto VA hospital for more than two decades.
Much of my time is spent on laboratory, translational and clinical research. In the laboratory, we are pursuing several projects related to the questions of why pain sometimes becomes chronic after injuries and why opioids lose their effectiveness over time. Alterations in endogenous pain control mechanisms and the involvement of the adaptive system of immunity are central to these investigations. We would like to find ways to maximize functional recovery after surgery and other forms of trauma while minimizing the risks of analgesic use. This work involves local, national and international collaborations. Clinical trials work involves establishing the efficacy of novel forms of analgesic therapy as well as the comparative effectiveness of long-established approaches to controlling common forms of pain such as low back pain. This spectrum of pain-related pursuits continues to evolve with the rapid expansion of the field. -
John Clarke
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioDr. John Clarke recently joined the Gastroenterology & Hepatology Division at Stanford University as Director of the Esophageal Program. He previously spent 17 years in Baltimore, including 9 years on the faculty at Johns Hopkins University where he was an Associate Professor and at various times Director of Esophageal Motility, Director of Gastrointestinal Motility, Clinical Director of the Johns Hopkins Center for Neurogastroenterology, and Clinical Director of the Gastroenterology & Hepatology Division at Johns Hopkins Bayview Medical Center.
His career has combined research, education and clinical care. His clinical areas of expertise include achalasia, dysphagia, eosinophilic esophagitis, esophageal dysmotility, gastroesophageal reflux disease, gastroparesis, GI-manifestations of scleroderma and GI dysmotility. While at Johns Hopkins University, he was inducted into The Miller-Coulson Academy for Clinical Excellence, an institutional honor society for master clinicians at the time limited to 50 members across the entire university.
From an education standpoint, he has lectured in over a dozen countries, authored over 25 textbook chapters and serves on the educational affairs committee of the American College of Gastroenterology. He has also won several major teaching awards, including The Johns Hopkins University Alumni Association Award for Excellence in Teaching, given to one faculty member per year in the entire School of Medicine.
His research has focused on optimization and characterization of diagnostic studies to evaluate motility disorders, as well the relationship between therapeutic endoscopic techniques and treatment of motility disorders. He was an investigator on the NIH Gastroparesis Consortium and is also a former recipient of the AGA Don Castell Award. -
Michael F. Clarke, M.D.
Karel H. and Avice N. Beekhuis Professor of Cancer Biology
Current Research and Scholarly InterestsDr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.
-
Shoa L. Clarke, MD, PhD
Assistant Professor of Medicine (Stanford Prevention Research Center) and of Pediatrics (Cardiology)
BioDr. Clarke is a preventive cardiologist and a physician-scientist focused on disease prevention. He earned his undergraduate degree in human biology from the Division of Nutritional Sciences at Cornell University before obtaining his MD and PhD (genetics) from Stanford University School of Medicine. He has completed clinical training in internal medicine (Brigham & Women’s Hospital), pediatrics (Boston Children’s Hospital), and cardiovascular medicine (Stanford Hospital), and he is board certified in all three specialties. His research is focused on 1) understanding complex disease genetics in diverse populations, 2) integrating monogenic and polygenic risk with clinical risk, 3) large-scale phenotyping using the electronic health record and medical images. His clinical practice focuses on identifying risk factors for cardiovascular disease with the goal of promoting health and longevity through evidence-based personalized treatment. He is interested in developing family-centric approaches for the treatment of adults and children carrying genetic risk for disease.
-
Stephanie Clarke
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Stephanie Clarke is a Licensed Clinical Psychologist and Clinical Assistant Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Clarke is an expert in the treatment of suicidal and self-harming behavior in adolescents, with additional expertise in evidence-based treatment of trauma and restrictive eating disorders in adolescents. She is intensively trained in Dialectical Behavior Therapy (DBT), currently the only well-established treatment for self-harming adolescents at high risk for suicide. Dr. Clarke is an Attending Psychologist and supervisor in Stanford’s Adolescent DBT Program, Eating Disorders Clinic, and Comprehensive Care Program (CCP, inpatient unit for medical issues related to disordered eating), where she specialized in seeing complex cases with multiple diagnoses (e.g., comorbid Anorexia Nervosa and suicidality/self-harm). She was the Stanford Psychologist in the DBT Intensive Outpatient Program, RISE, a collaboration between Stanford and Children’s Health Council, where she was in charge of training and supervision of psychology trainees. Dr. Clarke also provides education and training to psychology and psychiatry trainees in DBT, Acceptance and Commitment Therapy (ACT), suicidality, self-harm, mood disorders, eating disorders, and trauma. Dr. Clarke has given numerous talks, trainings, and lectures and has co-authored several publications on the topics of adolescent suicide, self-harming behavior, and DBT.
In 2020, Dr. Clarke was the recipient of the Department of Psychiatry and Behavioral Science's Clinical Innovation and Service Award. Dr. Clarke was also awarded funding from the Professional Leadership Development Awards Program for the 20-21 academic year, which supports the career development of department faculty who exhibit particular promise in advancing into leadership roles in academic medicine. Dr. Clarke has been funded by a grant from the Department of Psychiatry and Behavioral Sciences and the Maternal and Child Health Research Institute to study the safety and feasibility of providing exposure-based trauma treatment to suicidal teens in stage I DBT.
Dr. Clarke also maintains a small private practice, where she provides consultation, parent coaching, and individual therapy for adolescents and adults using DBT, FBT, exposure and response prevention, ACT, compassion-focused, and other CBT and evidence-based approaches. -
Carol Clayberger
Professor (Research) of Pediatrics, Emerita
Current Research and Scholarly InterestsOur group uses molecular biology, biochemistry, and cellular immunology to investigate the activation and effector function of T lymphocytes. Research in the laboratory is currently focused on three areas: granulysin, a lytic molecule expressed late (7-12 days) after T cell activation; identification of correlates of immunity in diseases such as tuberculosis; and tolerance. The long term goal of this work is to develop new ways to treat human disease.
-
Michael Cleary
Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology, Emeritus
Current Research and Scholarly InterestsThe role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.
-
William Clusin, MD
Associate Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsCardiac action potentials; tissue culture, voltage, clamp technique; role of calcium in ischemia arrhythmias; coronary, artery disease; myocardial infarction.
-
Maria Inmaculada Cobos Sillero
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab uses cellular and molecular methods, single-cell technology, and quantitative histology to study human neurodegenerative diseases. Current projects include:
- Using single-cell RNA-sequencing to understand selective vulnerability and disease progression in human Alzheimer’s disease brain
- Investigating mechanisms of tau-related neurodegeneration in human brain
- Studying the neocortical and limbic systems in Diffuse Lewy Body Disease (DLBD) at the single cell level -
Jennifer R. Cochran
Vice President for SLAC National Accelerator Laboratory and for Strategic Initiatives, Addie and Al Macovski Professor, Professor of Bioengineering and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsMolecular Engineering, Protein Biochemistry, Biotechnology, Cell and Tissue Engineering, Molecular Imaging, Chemical Biology
-
Nathaniel Lee Coggins
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Clinical Assistant Professor, Emergency MedicineBioNathaniel Coggins, M.D. is a palliative care and emergency medicine physician specializing in the implementation and dissemination of palliative care in the emergency department setting. Dr. Coggins holds dual-appointments as Clinical Assistant Professor in the Departments of Medicine and Emergency Medicine and is the Physician Co-Lead for the Stanford Emergency Palliative Care Program.
Dr. Coggins received his medical degree from the David Geffen School of Medicine at UCLA in 2019, where he was a recipient of the David Geffen Medical Scholarship. He completed his emergency medicine residency training at UCLA and hospice and palliative medicine fellowship training at the University of Utah. Dr. Coggins joined Stanford University as faculty in 2024, where he is an attending physician on the inpatient palliative care service and in the adult emergency department. -
Harvey Cohen
Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics, Emeritus
Current Research and Scholarly InterestsMy research interests extend from hypothesis-driven studies in biochemistry and cell biology to discovery-driven interests in proteomics and systems biology to clinical treatment of acute lymphoblastic leukemia of children, and pediatric palliative care.
-
Mitchell B Cohen
Elizabeth Wood Dunlevie Professor and Senior Associate Dean, Maternal and Child Health
BioMitchell B. Cohen, M.D., is a Professor in the Department of Pediatrics in the School of Medicine. He serves as the Chief Medical Officer for Stanford Medicine Children’s Health and the Senior Associate Dean in the School of Medicine for Maternal and Child Health. From 2014-2024, he was the Katharine Reynolds Ireland Chair of Pediatrics at the University of Alabama at Birmingham and the Physician-in-Chief of Children’s of Alabama. Prior to that, he served as the Director of Gastroenterology, Hepatology and Nutrition and Vice Chair of Pediatrics at Cincinnati Children’s Hospital Medical Center.
Dr. Cohen was the founding Director of the P30 Cincinnati Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Diseases His research focused on the mechanism of action of E. coli heat stable enterotoxin, a worldwide cause of infant diarrhea. His laboratory identified that increased guanylyl cyclase (GC-C) receptors for this toxin contributed to the increased susceptibility and severity of diarrhea seen in infants. Identification of the endogenous ligands for GC-C, guanylin and uroguanylin, led to development of knockout mice and an evolving understanding of intestinal secretion and pharmacologic treatment through this ligand-receptor family. Dr. Cohen had a long-standing NIH-supported program of vaccine trials for enteric infection, including a validated human cholera challenge model which resulted in licensure of a cholera vaccine.
Dr. Cohen has held leadership positions in several professional capacities. He served as the only pediatrician on the NIH Commission on Digestive Diseases; he was chair of the Section on Growth, Development and Nutrition of the American Gastroenterological Association (AGA) and the Section on Gastroenterology, Hepatology and Nutrition (SOGHN) of the American Academy of Pediatrics; he was President of NASPGHAN, the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Dr. Cohen was elected to membership in the Association of American Physicians and has received several lifetime achievement awards, including the Shwachman Award from NASPGHAN, the Saul Horowitz Jr. Award from Mt. Sinai, and the UAB Department of Pediatrics Lifetime Achievement Award. -
Sheila E. Cohen
Professor (Clinical) of Anesthesia, Emerita
Current Research and Scholarly InterestsOur obstetric anesthesia group is interested in a variety of topics including the efficacy and mechanism of action of spinal and epidural opioids for production of analgesia during labor, and the functionality of epidural analgesia for labor pain relief.
-
Stanley N. Cohen, MD
Kwoh-Ting Li Professor in the School of Medicine, Professor of Genetics and of Medicine
On Partial Leave from 06/04/2025 To 07/16/2026Current Research and Scholarly InterestsWe study mechanisms that affect the expression and decay of normal and abnormal mRNAs, and also RNA-related mechanisms that regulate microbial antibiotic resistance. A small bioinformatics team within our lab has developed knowledge based systems to aid in investigations of genes.
-
Elana Trubowitch Cohn
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Elana Cohn (She/Her) is a board-certified Family Physician, with a love for caring for the whole person and the entire family.
She completed her bachelor's degree in Neuroscience and Behavior at Barnard College, after which she worked as a Health Outreach coordinator on a mobile medical van providing care to the homeless population in NY, which sparked her love for primary care. She received her medical degree at Tel aviv University, and completed her residency at Mount Sinai and the Institute for Family Health.
Her practice spans care for all ages, with an emphasis on care for marginalized populations, reproductive health, office based-procedures, and teaching. She is passionate about integrating mental health care and reproductive justice into general practice, and making care for her patients as comprehensive as possible.
Outside of the office, she loves to travel and explore new places, dance her heart out, and spend time with her family. -
Todd Coleman
Associate Professor of Bioengineering and, by courtesy, of Electrical Engineering
BioTodd P. Coleman is an Associate Professor in the Department of Bioengineering, and by courtesy, Electrical Engineering at Stanford University. He received B.S. degrees in electrical engineering (summa cum laude), as well as computer engineering (summa cum laude) from the University of Michigan (Go Blue). He received M.S. and Ph.D. degrees from MIT in electrical engineering and computer science. He did postdoctoral studies at MIT and Mass General Hospital in quantitative neuroscience. He previously was a faculty member in the Departments of Electrical & Computer Engineering and Bioengineering at the University of Illinois, Urbana-Champaign, and the University of California, San Diego, respectively. Dr. Coleman’s research is very multi-disciplinary, using tools from applied probability, physiology, and bioelectronics. Examples include, for instance, optimal transport methods in high-dimensional uncertainty quantification and developing technologies and algorithms to monitor and modulate physiology of the nervous systems in the brain and visceral organs. He has served as a Principal Investigator on grants from the NSF, NIH, Department of Defense, and multiple private foundations. Dr. Coleman is an inventor on 10 granted US patents. He has been selected as a Gilbreth Lecturer for the National Academy of Engineering, a TEDMED speaker, and a Fellow of IEEE as well as the American Institute for Medical and Biological Engineering. He recently served as Chair of the National Academies Standing Committee on Biotechnology Capabilities and National Security Needs.
-
A. Dimitrios Colevas, MD
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
On Partial Leave from 10/01/2025 To 04/15/2026Current Research and Scholarly InterestsMulti- modality treatment of Head and Neck Cancer
Phase 1 clinical trials -
Roy Collins, MD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Roy Collins, MD is a board-certified psychiatrist and Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. He serves as an Attending Sports Psychiatrist and conducts mental performance research with the Wu Tsai Human Performance Alliance, supporting athletes across collegiate, professional, and international levels. Dr. Collins is the founder of the nation’s first Sports and Performance Psychiatry Fellowship, a pioneering program that provides advanced training in athlete mental health and performance psychiatry. His work bridges clinical expertise, lived experience, elite athletic background, and a commitment to advancing science in service of mental wellness and human performance.
-
Ruben J Colman, MD, PhD
Assistant Professor of Pediatrics (Gastroenterology)
BioDr. Colman is a pediatric gastroenterologist and physician-scientist with an overarching goal to improve and optimize the quality of care and outcomes for children with inflammatory bowel diseases (IBD) through precision medicine approaches. His interdisciplinary team science research program focuses on making precision medicine clinically actionable through innovative solutions merging clinical pharmacology knowledge with ‘-omics’ discoveries using microbiome and metabolomics signatures. Part of this work includes translating these findings into improved clinical treat-to-target endpoints with immediate noninvasive point-of-care measures such as intestinal ultrasound.
The foundation of his current work originates from his PhD titled ‘Precision Dosing and Personalized Medicine in pediatric IBD’. During his training, Dr. Colman was also an American Gastroenterological Association (AGA) editorial fellow for Gastroenterology and he is actively involved in the committees of several professional societies including the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), the Crohn’s and Colitis Foundation and the International Bowel UltraSound (IBUS) Group. Dr. Colman is supported by a Career Development K23 Award from the NIH, which focuses on evaluating personalized treatment strategies for children with Crohn's disease, specifically examining microbial and transmural intestinal ultrasound findings. He is also funded by awards of the NASPGHAN Foundation and the Stanford Pediatrics Physician-Scientist Bridge to K Program. -
Craig V. Comiter
Professor of Urology and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsUsing various animal models of bladder outlet obstruction as a representation of human prostatic disease, I am investigating how intervening with pharmacotherapy, neuromodulation, and other novel therapies may help to reverse the adverse changes in the bladder due to the obstruction.
I also am investigating new, minimally invasive treatments for post-prostatectomy urinary incontinence.
I am also investigating the role of neruomodulation in the treatment of chronic pelvic pain and IC. -
Le Cong
Associate Professor of Pathology (Pathology Research) and of Genetics
Current Research and Scholarly InterestsOur lab develops gene-editing technologies like novel CRISPR systems and large gene insertion techniques for gene and cell therapy. We also leverage these gene-editing tools for single-cell functional screening to probe mechanisms of cancer, immunological, and aging-associated diseases. To accelerate our work, we integrate AI and machine learning to design and evolve therapeutic RNAs/proteins, and build AI-XR co-scientists like LabOS that bridge AI computation and biomedical experimentation.
-
Christos E. Constantinou
Associate Professor of Urology, Emeritus
Current Research and Scholarly InterestsMy main recent interest is the application of Biomedical Engineering approaches for the clinical visualization and characterization of the static and dynamic properties of pelvic floor function. This extends to ultrasound Imaging and image processing, construction of computer models and biomechanics analysis of pelvic floor function. It is envisioned that these considerations are important constituents of the clinical evaluation of patients with lower urinary tract dysfunction and urodynamics.
-
Caitlin Contag
Clinical Scholar, Medicine - Pulmonary, Allergy & Critical Care Medicine
Postdoctoral Scholar, Pulmonary and Critical Care MedicineCurrent Research and Scholarly InterestsEmerging pathogens, high-consequence pathogens, critical care in resource limited settings, early interventions for sepsis, marginalized patient populations, sexually transmitted diseases, planetary health
-
Christopher H. Contag
Professor of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsWe develop and use the tools of molecular imaging to understand oncogenesis, reveal patterns of cell migration in immunosurveillance, monitor gene expression, visualize stem cell biology, and assess the distribution of pathogens in living animal models of human biology and disease. Biology doesn't occur in "a vacuum" or on coated plates--it occurs in the living body and that's were we look for biological patterns and responses to insult.
-
Jennifer Conti, MD, MS, MSc
Adjunct Clinical Assistant Professor, Obstetrics & Gynecology - General
Current Research and Scholarly InterestsClinical decision making around abortion choices; pain management with abortion
-
Simon Conti
Clinical Associate Professor, Urology
BioI am a founding member of the Stanford Urolithiasis Project, where we have studied population health datasets to examine surgical outcomes and environmental risk factors in urinary stone disease. Our current focus includes socioeconomic and ethnic disparities in kidney stone disease, water quality and stone disease, pregnancy in kidney stone disease and geographical variations in kidney stones incidence and metabolic kidney stone work up.
-
Marimar Contreras Nieves
Clinical Scholar, Medicine - Nephrology
Postdoctoral Scholar, NephrologyBioI am currently in my second year of nephrology fellowship, working on a Masters in clinical research and epidemiology, and also doing postdoctoral research on a U2C-TL1. During my training I have worked on clinical research focused on environmental risk factors and health care barriers that can initiate or accelerate the development and progression of kidney disease. My goal is to reach disadvantaged populations and help reduce the gaps in health that may stem from their vulnerability to determinantal environmental exposures. My projects have included investigating chronic kidney disease of uncertain etiology, with particular interest in California’s Central Valley.
-
John P. Cooke, MD, PhD
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsOur translational research program in vascular regeneration is focused on generating and characterizing vascular cells from human induced pluripotential stem cells. We are also studying the therapeutic application of these cells in murine models of peripheral arterial disease. In these studies we leverage our longstanding interest in endothelial signaling, eg by nitric oxide synthase (NOS) as well as by nicotinic cholinergic receptors (nAChR).
-
Margaret Cooke, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Cooke is a clinical assistant professor in the Department of Orthopaedic Surgery at Stanford University School of Medicine. She has a strong clinical interest in hand, wrist, and elbow surgery for adult and pediatric patients. She is dual fellowship trained in Hand & Upper Extremity Surgery and Pediatric & Congenital Hand Surgery.
As an orthopaedic surgeon, Dr. Cooke’s goal is to alleviate pain and improve hand, wrist, and elbow function so that her patients can return to the activities they enjoy. Her primary clinical interests are nerve compression (carpal tunnel), nerve injuries (traumatic/lacerations), joint instability/arthritis (degenerative conditions of the hand wrist and elbow), sports/athletic injuries, fracture care, and pediatric & congenital conditions of the hand and upper extremity.
Dr. Cooke utilizes a multi-disciplinary approach in order to provide comprehensive care for each patient. She works closely with colleagues from oncology, radiology, physical therapy, and other specialties. Her team includes certified hand therapists, cast technicians, medical assistants, and patient care coordinators. Together, Dr. Cooke and her team are committed to providing the best possible care for patients.
She invites patient referrals as early as possible when an upper extremity problem is suspected. She ensures a trusting relationship with referring physicians (whether primary care providers or specialists) by staying in communication so they understand and are comfortable with her recommendations.
In addition to patient care, Dr. Cooke has enjoyed contributing to her field through research. Among Dr. Cooke’s clinical research interests is fracture healing, including gene expression following administration of medication to stimulate bone repair. She has authored articles on topics like infection prediction and pain management after surgical repair of fractures. Her work has appeared in the Journal of Orthopaedic Trauma, Journal of Orthopaedic Research, Osteoarthritis & Cartilage, Spine, and Transplantation. She also co-wrote the chapter “The History of Carpal Tunnel” for the textbook Carpal Tunnel Syndrome and Related Median Neuropathies.
Dr. Cooke’s honors include a Howard Hughes Research Fellowship, an Outstanding Chief Resident Research Award, and recognition for authoring one of the top ten Foot & Ankle research papers at the 2016 American Academy of Orthopaedic Surgeons conference.
In addition to her practice in the U.S., Dr. Cooke has traveled abroad as a physician volunteer to provide surgical services in underserved areas where there is no access to hand surgery specialists. In partnership with the surgeon-founded nonprofit organization Touching Hands, she has performed hand surgeries on adult and pediatric patients in Honduras. Dr. Cooke also has traveled with Shriners Hospital to treat children in Davao, Philippines. -
Allen Cooper
Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Current Research and Scholarly InterestsI have had a long standing interest in the liver's role in cholesterol and lipid metabolism. In the past this was focused on laboratory studies but currently involves human studies as part of my patient care responsibilities. In particular I am interested in the role of NAFLD (non-alcoholic fatty liver disease) in patients with Hepatitis C aand in post liver transplant patients.
-
Kate Corcoran, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Corcoran is a Clinical Professor in the Department of Psychiatry and Behavioral Sciences, where she is actively involved in teaching psychotherapy to graduate students, psychiatry residents, and postdoctoral fellows. She is the Curriculum Director of CBT Training for the Psychiatry Residency program, and she teaches CBT to first year graduate students in the Psy.D. Consortium program. She is also a supervisor in the ADAPT Clinic, where she supervises postdoctoral fellows and PGY3 residents in the provision of CBT. In her clinical practice, Dr. Corcoran specializes in cognitive-behavioral therapy (CBT), mindfulness-based interventions, and compassion-focused approaches for adults experiencing anxiety, stress, and depression.
-
Linda C. Cork, DVM, PhD
Professor of Comparative Medicine, Emerita
Current Research and Scholarly InterestsDr. Linda Cork is Professor Emerita and former department chair. Her research focused on the identification and characterization of animal models of human neurodegenerative diseases. Dr. Cork no longer accepts students for mentoring.
-
Joanne Cornbleet
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsAs medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.
-
David N. Cornfield
Anne T. and Robert M. Bass Professor of Pediatric Pulmonary Medicine
Current Research and Scholarly InterestsOver the past 20 years, the Cornfield Laboratory has focused upon basic, translational and clinical research, with a primary focus on lung biology. As an active clinician-scientist, delivering care to acutely and chronically ill infants and children, our lab focuses on significant clinical challenges and tried to use science to craft novel solutions to difficult clinical problems.
-
Steven M. Corsello
Assistant Professor of Medicine (Oncology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur laboratory operates at the intersection of functional genomics and chemical biology, with the goal of advancing novel molecular mechanisms of cancer inhibition to clinical use. We aim to 1) leverage phenotypic screening and functional genomics to determine novel anti-cancer mechanisms of small molecules, 2) develop new targeted therapy approaches against solid tumors, and 3) build a comprehensive community resource for drug repurposing discovery.
-
Ximena Corso Díaz
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsWe are interested in unraveling the roles of RNA-binding proteins (RBPs) and regulatory RNAs in retinal development and homeostasis.
RNA-binding proteins mediate functional integration of transcriptional and post-transcriptional machineries influencing various aspects of gene expression and RNA metabolism. Several RBPs have cell-type enriched expression patterns in the retina or cause blinding diseases, however their role in retinal development and function is poorly understood. We have identified several RBPs that interact with the photoreceptor-specific transcription factor NRL and are likely involved in development and homeostasis of this retinal cell-type. We are pursuing the following lines of research:
1) RBPs in retinal development and degeneration. We will study the role of RBPs in regulating retinal development and maintaining homeostasis. We will focus on RBPs enriched in the retina, their interactions with retinal transcription factors like NRL, and their relevance to retinal diseases.
2) RBPs in R-loop regulation in the retina. R-loops are triple-stranded structures created when RNA anneals to one of the strands of the DNA duplex. R-loops have many regulatory roles during gene expression and their dysregulation can be detrimental to genome integrity. We observed that R-loops are dynamic during retinal development and identified key R-loop-associated RBPs that are enriched in rod photoreceptors and that interact with the transcription factor NRL. We will study the role of R-loops and their regulatory RBPs in retinal development and homeostasis.
3) Chromatin-associated regulatory RNAs through the retina lifespan. Chromatin-associated RNAs contribute to the dynamic regulation of gene expression, chromatin structure, and genome organization, playing essential roles in various biological processes, including development, differentiation, and disease. We will study how regulatory RNAs, together with their cognate RBPs, influence expression programs and chromatin dynamics through the retina lifespan. -
Victoria Cosgrove
Assistant Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development)
Current Research and Scholarly InterestsDr. Cosgrove studies putative roles for life and family stress as well as inflammatory and neurotrophic pathways in the etiology and development of mood disorders across the life span.
-
Helio Costa
Affiliate, Biomedical Informatics (BMI) graduate training program
BioHelio Costa, PhD, is a medical geneticist specializing in oncology, genomics, computational biology, data science, artificial intelligence, and product development. His work focuses on developing new cancer therapies and medical software to improve cancer patient care. He currently serves as Senior Medical Director and Head of Molecular Therapeutics & Drug Development at Natera and is an Adjunct Clinical Assistant Professor in the Department of Pathology at Stanford Medical School.
Dr. Costa’s research spans the entire drug development pipeline, from discovery to FDA-approved therapies. He leads efforts in developing innovative cancer treatments by integrating advanced genomics, computational biology, and AI-driven methodologies. His team focuses on the creation of targeted molecular therapeutics, using large-scale genetic data to identify novel treatment pathways and predict patient responses. In addition to drug discovery, Dr. Costa oversees the clinical trials necessary for validating these therapies, ensuring they meet rigorous standards for safety and efficacy. Furthermore, he manages the product development and commercialization process, guiding new treatments from initial research through to market-ready, FDA-approved cancer therapies.
In addition to his therapeutic work, Dr. Costa has led the development and implementation of genetic diagnostic tests and clinical algorithms used to support therapeutic decisions at Stanford Health Care. His contributions include the creation of DNA and RNA cancer diagnostic tests, as well as algorithms that analyze large-scale laboratory datasets and electronic medical records to predict patient outcomes. As a co-investigator with the NIH Clinical Genome Resource (ClinGen) Consortium, Dr. Costa oversaw developing FDA-recognized medical software used by healthcare providers, researchers, and biotech companies to assess the clinical relevance of genes and mutations.
He is the founding director of the Stanford Clinical Data Science Fellowship, where post-doctoral medical fellows engage in interdisciplinary clinical research and implement real-world health data solutions within Stanford Health Care. Dr. Costa is also an Attending Medical Geneticist for the Molecular Genetic Pathology Laboratory at Stanford Health Care, where he previously served as Assistant Lab Director.
Dr. Costa holds a BS in Genetics from the University of California, Davis, a PhD in Genetics from Stanford University School of Medicine, and completed his ABMGG Clinical Molecular Genetics and Genomics fellowship training at Stanford University School of Medicine.
